
ICCDTMC 2021: 15. International Conference on Chemotherapeutic Drugs, Tetracyclines, Macrolides and Clindamycin
- 会议时间:2021-03-29 至 2021-03-30
- 会议地点: Singapore, Singapore,Sydney,Australia 周边酒店预订
发票类型:
不支持开票
参会凭证:其它
Participation Type | Early Registration Fees | Registration Fees |
---|---|---|
Non-Student Oral/Poster Presenter Registration | € 450 | € 500 |
Student Oral/Poster Presenter Registration | € 350 | € 400 |
Listener Registration | € 250 | € 300 |
Additional Paper Publication | € 100 |
The International Research Conference Aims and Objectives
The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations. With its high quality, it provides an exceptional value for students, academics and industry researchers.
ICCDTMC 2021: 15. International Conference on Chemotherapeutic Drugs, Tetracyclines, Macrolides and Clindamycin aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Chemotherapeutic Drugs, Tetracyclines, Macrolides and Clindamycin. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Chemotherapeutic Drugs, Tetracyclines, Macrolides and Clindamycin
Call for Contributions
Prospective authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters. Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Chemotherapeutic Drugs, Tetracyclines, Macrolides and Clindamycin are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of novel research materials.
Guidelines for Authors
Please ensure your submission meets the conference's strict guidelines for accepting scholarly papers. Downloadable versions of the check list for Full-Text Papers and Abstract Papers.
Please refer to the Paper Submission Guideline, Abstract Submission Guideline and Author Information before submitting your paper.
Conference Proceedings
All submitted conference papers will be blind peer reviewed by three competent reviewers. The peer-reviewed conference proceedings are indexed in the Open Science Index, Google Scholar, Semantic Scholar, Zenedo, OpenAIRE, BASE, WorldCAT, Sherpa/RoMEO, and other index databases. Impact Factor Indicators.
Special Journal Issues
ICCDTMC 2021 has teamed up with the Special Journal Issue on Chemotherapeutic Drugs, Tetracyclines, Macrolides and Clindamycin. A number of selected high-impact full text papers will also be considered for the special journal issues. All submitted papers will have the opportunity to be considered for this Special Journal Issue. The paper selection will be carried out during the peer review process as well as at the conference presentation stage. Submitted papers must not be under consideration by any other journal or publication. The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly. Selected full-text papers will be published online free of charge.
Conference Sponsor and Exhibitor Opportunities
The Conference offers the opportunity to become a conference sponsor or exhibitor. To participate as a sponsor or exhibitor, please download and complete the Conference Sponsorship Request Form.
Application Forms
Selected Papers
- Use of Curcumin in Radiochemotherapy Induced Oral Mucositis Patients: A Control Trial Study
Shivayogi Charantimath - Assessing Chemo-Radiotherapy Induced Toxicity and Quality of Life of Cancer Patients
A. Taqaddas - Establishment and Evaluation of Information System for Chemotherapy Care
Yi-Ting Liu, Pei-Ying Wen - Chemotherapy Safety Protocol for Oncology Nurses: It's Effect on Their Protective Measures Practices
Magda M. Mohsen, Manal E. Fareed - HIV Treatment Planning on a case-by-CASE Basis
Marios M. Hadjiandreou, Raul Conejeros, Ian Wilson
Venkatesh Gunasekaran | The Tamil Nadu Dr. M.G.R. Medical University, IN |
Milena Miljkovic | PrimeVigilance Ltd, GB |
Lola Alimkhodjaeva | National Research Center of Oncology, |
Dina Mansour | National Research Centre (NRC), EG |
Bhumika Desai | C.K.Pithawalla Institute of Pharmaceutical Science & Research, IN |
Saurabh Gupta | Chitkara College of Pharmacy, IN |
Hayk Arakelyan | Panarmenian Association of Laser Therapy and Integrative Medicine, AM |
Kyi Kyi Tha | Monash University, Sunway Campus, MY |
Muhammad Nisar Khan | University of Agriculture, PK |
Gamal Enan | Zagazig University, EG |
Abstracts/Full-Text Paper Submission Deadline | January 06, 2020 | |
Notification of Acceptance/Rejection | January 28, 2020 | |
Final Paper (Camera Ready) Submission & Early Bird Registration Deadline | February 28, 2021 | |
Conference Dates | March 29-30, 2021 |
- ICCTHDGD 2021: 15. International Conference on Current Trends in Health and Disease and Gender Disparities
- ICLRG 2021: 15. International Conference on Local and Regional Government
- ICHMS 2021: 15. International Conference on Health and Medical Sociology
- ICEG 2021: 15. International Conference on Energy and Geomechanics